Personalized P2Y₁₂ Inhibitor Treatment: Are We Ready to Go?

Affiliations

¹ Department of Cardiology, St. Antonius Hospital, Nieuwegein, the Netherlands. Electronic address: jurtenberg@gmail.com.
² Department of Cardiology, St. Antonius Hospital, Nieuwegein, the Netherlands.

Free article

Editorial

Jurriën M Ten Berg et al. JACC Cardiovasc Interv. 2020.

Free article

. 2020 Mar 9;13(5):631-633.

doi: 10.1016/j.jcin.2020.01.221.

¹ Department of Cardiology, St. Antonius Hospital, Nieuwegein, the Netherlands. Electronic address: jurtenberg@gmail.com.
² Department of Cardiology, St. Antonius Hospital, Nieuwegein, the Netherlands.

No abstract available

Keywords: CYP2C19; P2Y(12) inhibitors; genotyping; tailored treatment.

Comment on

Routine CYP2C19 Genotyping to Adjust Thienopyridine Treatment After Primary PCI for STEMI: Results of the GIANT Study.
Hulot JS, Chevalier B, Belle L, Cayla G, Khalife K, Funck F, Berthier R, Piot C, Tafflet M, Montalescot G; GIANT Investigators. Hulot JS, et al. JACC Cardiovasc Interv. 2020 Mar 9;13(5):621-630. doi: 10.1016/j.jcin.2020.01.219. JACC Cardiovasc Interv. 2020. PMID: 32139220